Monika Ernst

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 2.8K citations · Full text

Metabolic Syndrome, Diabetes Management, Cardiovascular Disease +9

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 600 citations · Full text

Metabolic Syndrome, Diabetes Management, Urology +10

DMA polymorphisms in adhesion molecule genes ? a new risk factor for early atherosclerosis

Katrin Wenzel, Monika Ernst, Klaus Rohde et al. · Human Genetics · 1996 · 117 citations

Vascular Disease, Adhesion Molecule Genes, Genetics +16

Relationship of polymorphisms in the renin-angiotensin system and in E-selectin of patients with early severe coronary heart disease

Katrin Wenzel, Anneke C. Blackburn, Monika Ernst et al. · Journal of Molecular Medicine · 1997 · 59 citations

Hypertension, Cardiovascular Disease, Genetic Epidemiology +10

Cardiomyopathy in Friedreich's ataxia‐assessment by cardiac MRI

Chris Meyer, G. Schmid, S Görlitz et al. · Movement Disorders · 2007 · 48 citations